An experimental medicine might sluggish the development of amyotrophic lateral sclerosis, or ALS, researchers reported Wednesday.
The analysis was supported partially by donations from the Ice Bucket Challenge, the social media sensation that raised greater than $200 million worldwide, NBC News reports.
The drug just isn’t a treatment, however it could assist sluggish the inexorable incapacity attributable to ALS, which quickly destroys the nerve cells that management the muscle tissues that permit us to maneuver, converse, eat and even breathe.
